Rights and permissions
About this article
Cite this article
Early access programme for ALS drug recommended in the US. Inpharma Wkly. 1042, 22 (1996). https://doi.org/10.2165/00128413-199610420-00047
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199610420-00047